Flakus, Mattison J.
Wuschner, Antonia E.
Wallat, Eric M.
Graham, Melissa
Shao, Wei
Shanmuganayagam, Dhanansayan
Christensen, Gary E.
Reinhardt, Joseph M.
Bayouth, John E.
Funding for this research was provided by:
National Institutes of Health (R01 CA166703)
Article History
Received: 22 November 2022
Accepted: 31 May 2023
First Online: 9 June 2023
Competing interests
: Joseph M. Reinhardt is a shareholder in VIDA Diagnostics, Inc. Gary E Christensen receives licensing fees from VIDA Diagnostics, Inc. and is a consultant and owns stock in PowerPollen, Inc., Ames IA. John E. Bayouth has ownership interest in MR Guidance, LLC (MRG), which has performed business with radiation oncology vendors used in this work. All other authors have nothing to disclose.